Heart Protection With SGLT2, GLP-1 Drugs for Diabetes Mediated by Age

(MedPage Today) -- The age of type 2 diabetes patients may alter the level of cardioprotection from two newer classes of anti-diabetic agents, a network meta-analysis suggested.
The relative reduction in major adverse cardiovascular events (MACE...